A descriptive analysis of drug acquisition costs to treat multiple sclerosis (MS) in brazil- The ministry of health (MOH) perspective
Abstract
Authors
R.F. Alexandre M. Mosca R.E. Schneiders I.R. Zimmermann J.M. do Nascimento C.A. Gadelha